Akumin (NASDAQ:AKU) Upgraded at Zacks Investment Research


Share on StockTwits

Akumin (NASDAQ:AKU) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports.

According to Zacks, “Akumin Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services principally in the United States. The company’s imaging procedures include MRI, CT, positron emission tomography, ultrasound, diagnostic radiology, mammography and other interventional procedures. Akumin Inc. is based in PLANTATION, Fla. “

Shares of NASDAQ AKU traded down $0.01 on Wednesday, hitting $2.99. The company’s stock had a trading volume of 1,974 shares, compared to its average volume of 43,718. Akumin has a 12-month low of $1.25 and a 12-month high of $3.78. The company has a 50 day simple moving average of $3.10.

Akumin Company Profile

Akumin Inc provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures.

Further Reading: What is an inverted yield curve?

Get a free copy of the Zacks research report on Akumin (AKU)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Akumin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akumin and related companies with MarketBeat.com's FREE daily email newsletter.